Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 0378-5053-05 - (carbidopa and levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 0378-5053
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: carbidopa and levodopa
Active Ingredient(s): 25; 250    mg/1; mg/1 & nbsp;   carbidopa and levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET, ORALLY DISINTEGRATING
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 0378-5053
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078893
Marketing Category: ANDA
Start Marketing Date: 20121019

Package Information of Carbidopa and Levodopa

Package NDC: 0378-5053-05
Package Description: 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-5053-05)

NDC Information of Carbidopa and Levodopa

NDC Code 0378-5053-05
Proprietary Name Carbidopa and Levodopa
Package Description 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0378-5053-05)
Product NDC 0378-5053
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name carbidopa and levodopa
Dosage Form Name TABLET, ORALLY DISINTEGRATING
Route Name ORAL
Start Marketing Date 20121019
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 250
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information